Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CB8W
|
||||
Former ID |
DIB010876
|
||||
Drug Name |
DE-081
|
||||
Synonyms |
Apafant (ophthalmic formulation), Santen
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Conjunctivitis [ICD9: 372; ICD10:H10] | Discontinued in Phase 2 | [544551] | ||
Company |
Santen Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H22ClN5O2S
|
||||
Canonical SMILES |
Cc1nnc2CN=C(c3ccccc3Cl)c4cc(CCC(=O)N5CCOCC5)sc4n12
|
||||
InChI |
1S/C22H22ClN5O2S/c1-14-25-26-19-13-24-21(16-4-2-3-5-18(16)23)17-12-15(31-22(17)28(14)19)6-7-20(29)27-8-10-30-11-9-27/h2-5,12H,6-11,13H2,1H3
|
||||
InChIKey |
JGPJQFOROWSRRS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Modulator | [534251] | |
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.